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margin status), more aggressive surgery and increasing use of
radiotherapy.
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O-58 FACTORS INFLUENCING LOCAL CONTROL IN PATIENTS
UNDERGOING BREAST CONSERVATION SURGERY FOR DUCTAL
CARCINOMA IN SITU
J. Mathew a, R. Karia a, N. Warrich a, D. Morgan b, A. Lee c, I. Ellis c, J.
Robertson a, A. Bello a. aDivision of Breast Surgery, Nottingham
University Hospitals, Nottingham, UK. bDepartment of Oncology,
Nottingham University Hospitals, Nottingham, UK. cDepartment of
Pathology, Nottingham University Hospitals, Nottingham, UK
Background: The aim of our study was to assess various
risk factors for local recurrence (LR) in patients undergoing
breast conservation surgery (BCS) for ductal carcinoma
in situ (DCIS).
Materials and methods: Retrospective case note review
between January 1975 and June 2008. In our hospital a margin
of P10 mm is considered acceptable. Patients were divided into
three groups based on pathological margin (<5 mm, 5–9 mm
and P10 mm). Cox regression model for multivariate analysis
of local recurrence was used with variables with significant P
values (<0.05) in the univariate analysis carried out using SPSS
version 16.
Results: Overall 239 women had BCS for DCIS during the above
period. The median age was 59 years (40–86) and the median fol-
low-up was 76 months (1–308). Pathological findings included
median size of 11 mm (1–50), 75 cases with comedo necrosis
and 5 patients with microinvasion (<1 mm). Overall 193 patients
had grades recorded (44 low grade, 54 intermediate grade and
95 high grade).
Overall LR rate was 17% (40/239), of which 65% (26/40) were
invasive recurrences. Thirty-one patients were 6 to 50 years
and 32% (10/31) developed LR compared to 14% (30/208) in
those above 50 years (P = 0.018). Forty-three percent of patients
(6/14) with <5 mm margin developed LR compared to 12% (3/
25) with 5–9 mm margin and 14% (27/188) with P10 mm mar-
gin. Four out of 12 patients with unknown margin status
developed LR. The LR rate in patients with <5 mm (6/14) mar-
gin was significantly higher compared to those with P5 mm
(30/213) margin (P value < 0.012). Three out of 5 patients with
microinvasion developed LR and it was statistically significant
(P = 0.034) compared to those without microinvasion. On multi-
variate analysis age 650 years, <5 mm pathological margin and
microinvasion were independent poor prognostic factors for
local recurrence.
Conclusion: Our study shows that younger age (650 years), a
clear margin <5 mm and associated microinvasion are poor prog-
nostic factors for LR in patients undergoing breast conservation
surgery for DCIS.
doi:10.1016/j.ejcsup.2010.06.059
O-59 SINGLE CENTRE EXPERIENCE OF 500 PATIENTS WITH
INTRA-OPERATIVE RT-PCR BREAST SENTINEL NODE ANALYSIS
V. Brown, R. Cutress, T. Simoes, A. Agrawal, M. Wise, I. Cree, C.
Yiangou. Portsmouth Breast Cancer Centre, Queen Alexandra Hospital,
Portsmouth, UK
Introduction: Tumour specific mRNA markers detected by real
time reverse transcriptase-polymerase chain reaction (RT-PCR)
have been used to detect breast cancer metastases in sentinel
lymph nodes. We present our experience of 500 consecutive cases
in a single centre.
Methods: All clinically and radiologically node negative
patients who underwent sentinel node biopsy (SLNB) were
included in the study over a 24-month period. SLNB was per-
formed according to New Start guidelines. Intraoperative anal-
ysis was performed on alternate slices at 2 mm intervals,
with the remaining slices sent for standard histological anal-
ysis. The GeneSearch assay (Veridex LLC, Warren, NJ) was
used to detect the expression of mammaglobin (MG) and
cytokeratin 19 (CK). Patients were considered SLNB positive
if one or more sentinel lymph nodes were positive for either
MG or CK.
Results: Sentinel lymph nodes (912) were analysed with an
average of 1.8 nodes per patient. The cohort was representative
Table 1
Time period 1988–1993 (n. 300) 1994–1997 (n. 319) 2000–2003 (n. 547)
Non-operative diagnosis 59 (20%) 142 (45%) 439 (80%)
Treatment
Mastectomy 134 (45%) 127 (40%) 205 (37%)
Wide local excision 123 (41%) 141 (44%) 294 (54%)
Diagnostic excision alone 43 (14%) 51 (16%) 48 (9%)
Radiotherapy (post conservation) 24 (15%) 25 (13%) 186 (54%)
Tamoxifen 139 (46%) 149 (47%) 240 (44%)
5 year LRR
Mastectomy 2 (1.5%) 3 (2.5%) 1 (0.5%)
Wide local excision 12 (10%) 17 (12%) 19 (6.5%)
Diagnostic excision alone 9 (22%) 6 (12%) 1 (2%)
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for tumour size, grade and histological type, and 26% were node
positive on histology.
Sensitivity Specificity Concordance
Per node 96% 95% 95%
Per patient 96% 94% 95%
The sensitivity for macrometastases was 99.8%.
Conclusion: Our experience of the use of RT-PCR for intraoper-
ative analysis of sentinel lymph nodes shows a highly favourable
concordance with histological analysis. It offers the ability to pro-
ceed to immediate axillary clearance and is, therefore, beneficial
to patients. It is consistent and reliable. We believe intra-opera-
tive analysis should be available to all patients undergoing SLNB
as part of breast cancer surgery.
doi:10.1016/j.ejcsup.2010.06.060
O-60 ONE-STEP NUCLEIC ACID AMPLIFICATION IN DETECTION
OF LYMPH NODE METASTASES IN BREAST CANCER PATIENTS:
ARE PATIENTS BEING OVER TREATED?
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Background and aims: One-step nucleic acid amplification
(OSNA) is an assay of cytokeratin 19 mRNA for intraoperative
detection of lymph node metastasis in breast cancer. Patients
who have micro-metastases proceed to level 1 axillary node clear-
ance (ANC) and those with macro-metastases or positive but
inhibited results to level 3 ANC, avoiding a second operation.
Presence or absence of micro-metastasis depends on the agreed
cut off point on the amplification curve. The aim of this study was
to review our data following introduction of OSNA and review the
outcome of ANC in patients with positive OSNA results.
Methods: Data were collected prospectively from the introduc-
tion of this technique to date (01/12/2008 to 06/05/2010). Opera-
tions have been performed by four consultant breast surgeons.
Results: Three hundred and ten patients had 641 nodes analysed
in the study period. 69% had wide local excision, 28% mastectomy
and 7% SNB alone. Thirty-four percent had positive sentinel nodes
and had further axillary surgery. Of these 39% had micro-metasta-
ses and 61% had macro-metastases or positive but inhibited results.
Of the patients with micro-metastases 10% had further positive
non-sentinel nodes. 41.2% of the patients with macro-metastases
or positive but inhibited results had positive non sentinel nodes.
Conclusion: Over a third of patients had positive lymph nodes
detected with OSNA and underwent ANC, eliminating the need
for a second operation. Only 10% of patients with micro-metasta-
ses have further positive non-sentinel nodes. National trials are
underway to determine if axillary clearance should be considered
the correct option for this cohort of patients.
doi:10.1016/j.ejcsup.2010.06.061
O-61 ARGON BEAM COAGULATOR IN BREAST SURGERY: EFFECT
ON THE INCIDENCE OF BREAST SEROMA
V. Lefemine, W. Samra. Glan Clwyd Hospital, Rhyl, UK
Aim: To compare the incidence of breast seroma following
mastectomy, upon the use of argon beam coagulator (ABC) or con-
ventional monopolar diathermy (MD).
Method: Data were collected retrospectively from January 2006
to August 2008 for all patients undergoing a simple mastectomy.
Postoperative incidence of seroma, amount of drainage on day
of discharge and number of days from drain removal to seroma
formation were recorded.
Results: Fifty-six patients were studied, comparison were
made for those who underwent a simple mastectomy using
ABC (30 women) or MD (25 women). The two groups were similar
with regard to age, type of axillary surgery and operative time.
The incidence of postoperative breast seroma development was
30% in the former group and 36% in the latter. In the ABC group
a high postoperative drainage (>50 ml/24 h) on the day of drain
removal was associated with a higher incidence of seroma,
whereas this was not observed in the MD group.
Discussion: The ABC has been recommended as tool of choice
in patients undergoing mastectomy as it significantly reduces
blood loss. Its impact on the incidence of breast seroma is still
under scrutiny. Our results failed to show any statistically signif-
icant difference (p value = 0.275) in the incidence of breast seroma
amongst the MD (36%) and the ABC (30%) group. ABC is more
costly than the standard MD and their use need to be carefully
considered in an era of over-stretched NHS financial budget.
The need for further randomized studies is unquestionable.
doi:10.1016/j.ejcsup.2010.06.062
O-62 ONCOPLASTIC SURGERY: WHO IS DOING WHAT?
J. Skillman a, L. Whisker b, D. England b, M. Hallissey b. aUniversity
Hospital of Coventry and Warwickshire, Coventry, UK. bUniversity
Hospital, Birmingham, UK
Oncoplastic breast surgery combines plastic surgery tech-
niques and breast cancer resection to improve cosmesis. Does
its high profile reflect current practice?
Aims: Which oncoplastic procedures are being provided by
whom? What are their concerns, do they agree with guidelines?
Methods: A questionnaire was distributed to members of the
Association of Breast Surgery and BAPRAS.
Results: Two hundred and twenty eight surgeons responded (70
plastics (P), 158 breast (B)) of whom 41% thought oncoplastic sur-
gery should be universally available.
Ipsilateral procedures were usually performed by general sur-
geons with oncoplastic training (90) or in a combined case (68).
Breast surgeons were more likely to use rearrangement tech-
niques (therapeutic mammaplasty (33%P, 40%B), Grisotti flaps
(17%P, 27%B)) than plastic surgeons, who were more likely to
use reconstructive procedures (LD flap (79%P, 52%B), tissue
expanders (73%P, 47%B)). Therapeutic mammaplasty was felt to
be under-utilized.
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